Skincare & eye care
cleanse · prepare · target a visible concern · moisturize · support the skin barrier · protect as labeled · care for the eye area
governed appendix · verified 2026-07-10
Every registered current clinical claim. Kept in scope.
This appendix gathers all 47 registered claims for current finished products and named regimens in the governed evidence library.
The catalogue is designed to support a connected set of cosmetic and performance benefits. No whole-line clinical study is registered. Every result below remains attached to the exact current product or regimen that earned it.
the current catalogue map
Eight benefit territories, one day-to-night rhythm
Use these territories to find the product job first. Then open the exact product, directions, and evidence rather than treating the catalogue as one undifferentiated formula.
Lips
long-wear color · finish and shine · lip definition · comfort care · precision removal
Eyes, brows & lashes
eye color · liner definition · lash volume and wear · brow shape and fullness · under-eye brightening
Face color
prime · even visible tone · build coverage · correct contrast · add cheek color · sculpt · highlight · set the finish
Hair & scalp
cleanse hair and scalp · reset buildup · detangle and prime · support the look of density, strength, or volume · refresh between washes
Bath, body & men's grooming
cleanse · smooth · moisturize · deodorize · support a comfortable shave · extend daily care beyond the face
Nails
prepare the nail surface · add color · seal shine · condition cuticles · support a smoother-looking finish
Wellness & oral care
collagen supplementation · sleep-routine support as labeled · topical magnesium formats · daily oral care
current evidence · 3 registered claims
LipSense Cream (tested as LipSense Hydra Matte Lip Color)
current official product or collection · full clinical report
claim 01measured clinical result
At 4 hours, mean LipSense Cream appearance scores were 3.2 by trained-technician assessment and 3.4 by participant assessment on the study's 0-to-4 scale.
- Scope
- LipSense Hydra Matte Lip Color tested article, presented as LipSense Cream
- Endpoint
- mean lip-appearance score on the study's 0-to-4 scale
- Duration
- 4 hours after application
- Source
- Essex Testing Clinic, Panel 23076 / Entry 50474, n=32; final report April 4, 2023
claim 02measured clinical result
In the LipSense Cream forearm protocol, the mean product-transference score after rubbing was 0.4 on the study's 0-to-9 scale.
- Scope
- LipSense Hydra Matte Lip Color tested article, presented as LipSense Cream; 2 cm by 2 cm forearm site rubbed with a white towel
- Endpoint
- mean product-transference score on the study's 0-to-9 scale
- Duration
- approximately 5 minutes after application
- Source
- Essex Testing Clinic, Panel 23076 / Entry 50474, n=32; final report April 4, 2023
claim 03measured clinical result
After approximately 30 seconds of water exposure, all LipSense Cream technician and participant mean appearance scores remained 4.0 for both lips and forearm.
- Scope
- LipSense Hydra Matte Lip Color tested article, presented as LipSense Cream; lips splashed with water and forearm submerged in 27 degrees C water
- Endpoint
- mean appearance score after the specified brief water-exposure protocols
- Duration
- approximately 30 seconds of water exposure
- Source
- Essex Testing Clinic, Panel 23076 / Entry 50474, n=32; final report April 4, 2023
current evidence · 5 registered claims
Evening Moisturizer - Normal to Dry surface-turnover study
current official product or collection · full clinical report
claim 01measured clinical result
The treated SenePlex+ formula site showed 49% greater visible surface-cell turnover than the untreated control site at day 13.
- Scope
- Evening Moisturizer Normal to Dry SGF21090-01 treated site versus untreated control
- Endpoint
- visible surface-cell turnover
- Duration
- 20-day study; day-13 endpoint
- Source
- Essex Testing Clinic, Panel 22107, n=33; SENEPLEX-01-MASTER-DATA-TRUTH.md
claim 02measured clinical result
The treated SenePlex+ formula site showed 80% greater visible surface-cell turnover than the untreated control site at day 16.
- Scope
- Evening Moisturizer Normal to Dry SGF21090-01 treated site versus untreated control
- Endpoint
- visible surface-cell turnover
- Duration
- 20-day study; day-16 endpoint
- Source
- Essex Testing Clinic, Panel 22107, n=33; SENEPLEX-01-MASTER-DATA-TRUTH.md
claim 03measured clinical result
The treated SenePlex+ formula site showed 94% greater visible surface-cell turnover than the untreated control site at day 17.
- Scope
- Evening Moisturizer Normal to Dry SGF21090-01 treated site versus untreated control
- Endpoint
- visible surface-cell turnover
- Duration
- 20-day study; day-17 endpoint
- Source
- Essex Testing Clinic, Panel 22107, n=33; SENEPLEX-01-MASTER-DATA-TRUTH.md
claim 04measured clinical result
In an independent 20-day study, a tested SenePlex+ Evening Moisturizer formula showed up to 100% greater visible surface-cell turnover than untreated skin by day 18.
- Scope
- Evening Moisturizer Normal to Dry SGF21090-01 treated site versus untreated control; not the 8-week regimen
- Endpoint
- visible surface-cell turnover
- Duration
- 20-day study; day-18 endpoint
- Source
- Essex Testing Clinic, Panel 22107, n=33, p<0.001; bible-current.txt:853-855
claim 05measured clinical result
Mean time to full visible surface turnover was 15.5 ± 0.4 days at the treated site versus 18.0 ± 0.4 days at the untreated control site.
- Scope
- Evening Moisturizer Normal to Dry SGF21090-01 treated site versus untreated control
- Endpoint
- mean time to full visible surface turnover
- Duration
- 20-day study
- Source
- Essex Testing Clinic, Panel 22107, n=33, p<0.001; SENEPLEX-01-MASTER-DATA-TRUTH.md
current named regimen · 16 registered claims
Normal-to-Dry three-product SenePlex+ regimen
current official product or collection · full clinical report
claim 01measured clinical result
The tested SenePlex+ regimen improved measured hydration by 49.99% immediately after application.
- Scope
- Normal-to-Dry 3-in-1 Cleanser, DayTime Moisturizer, and Evening Moisturizer regimen used together
- Endpoint
- measured hydration versus baseline
- Duration
- immediate
- Source
- Validated Claim Support LLC, CS211017, n=32, Corneometer, p<0.001
claim 02measured clinical result
The tested SenePlex+ regimen improved measured hydration by 12.5% at week 2.
- Scope
- Normal-to-Dry 3-in-1 Cleanser, DayTime Moisturizer, and Evening Moisturizer regimen used together
- Endpoint
- measured hydration versus baseline
- Duration
- 2 weeks
- Source
- Validated Claim Support LLC, CS211017, n=32, Corneometer, p<0.001
claim 03measured clinical result
The tested SenePlex+ regimen improved measured hydration by 12.0% at week 4.
- Scope
- Normal-to-Dry 3-in-1 Cleanser, DayTime Moisturizer, and Evening Moisturizer regimen used together
- Endpoint
- measured hydration versus baseline
- Duration
- 4 weeks
- Source
- Validated Claim Support LLC, CS211017, n=32, Corneometer, p<0.001
claim 04measured clinical result
The tested SenePlex+ regimen improved measured hydration by 28.62% at 8 weeks.
- Scope
- Normal-to-Dry 3-in-1 Cleanser, DayTime Moisturizer, and Evening Moisturizer regimen used together
- Endpoint
- measured hydration versus baseline
- Duration
- 8 weeks
- Source
- Validated Claim Support LLC, CS211017, n=32, Corneometer, p<0.001
claim 05measured clinical result
The tested SenePlex+ regimen improved measured firmness by 7.06% at week 2 on the Cutometer R0 parameter, where a lower value indicates firmer skin.
- Scope
- Normal-to-Dry regimen used together
- Endpoint
- measured firmness
- Duration
- 2 weeks
- Source
- Validated Claim Support LLC, CS211017, Cutometer R0, p=0.016
claim 06measured clinical result
The tested SenePlex+ regimen improved measured firmness by 6.59% at week 8 on the Cutometer R0 parameter, where a lower value indicates firmer skin.
- Scope
- Normal-to-Dry regimen used together
- Endpoint
- measured firmness
- Duration
- 8 weeks
- Source
- Validated Claim Support LLC, CS211017, Cutometer R0, p=0.033
claim 07measured clinical result
At week 8, expert grading found improved visible brightness, radiance, or luminosity in 96.88% of subjects using the tested regimen.
- Scope
- Normal-to-Dry regimen used together
- Endpoint
- expert-graded visible brightness, radiance, or luminosity
- Duration
- 8 weeks
- Source
- Validated Claim Support LLC, CS211017, n=32, expert grading, p<0.001
claim 08measured clinical result
At week 8, expert grading found improved visible firmness in 80.65% of subjects using the tested regimen.
- Scope
- Normal-to-Dry regimen used together
- Endpoint
- expert-graded visible firmness
- Duration
- 8 weeks
- Source
- Validated Claim Support LLC, CS211017, n=32, expert grading, p<0.001
claim 09measured clinical result
At week 8, expert grading found improved visible texture or smoothness in 71.88% of subjects using the tested regimen.
- Scope
- Normal-to-Dry regimen used together
- Endpoint
- expert-graded visible texture and smoothness
- Duration
- 8 weeks
- Source
- Validated Claim Support LLC, CS211017, n=32, expert grading, p<0.001
claim 10measured clinical result
At week 8, expert grading found improved visible tone evenness in 56.25% of subjects using the tested regimen.
- Scope
- Normal-to-Dry regimen used together
- Endpoint
- expert-graded visible tone evenness
- Duration
- 8 weeks
- Source
- Validated Claim Support LLC, CS211017, n=32, expert grading, p<0.001
claim 11measured clinical result
At week 8, expert grading found improvement in the appearance of fine lines or wrinkles in 31.25% of subjects using the tested regimen.
- Scope
- Normal-to-Dry regimen used together
- Endpoint
- expert-graded appearance of fine lines and wrinkles
- Duration
- 8 weeks
- Source
- Validated Claim Support LLC, CS211017, n=32, expert grading, p≤0.012
claim 12participant-perception result
At week 8, 100% of subjects agreed that skin felt more moisturized.
- Scope
- Normal-to-Dry regimen used together
- Endpoint
- consumer agreement: skin feels more moisturized
- Duration
- 8 weeks
- Source
- Validated Claim Support LLC, CS211017, n=32, consumer perception
claim 13participant-perception result
At week 8, 100% of subjects agreed that skin tone looked more supple.
- Scope
- Normal-to-Dry regimen used together
- Endpoint
- consumer agreement: skin tone looks more supple
- Duration
- 8 weeks
- Source
- Validated Claim Support LLC, CS211017, n=32, consumer perception
claim 14participant-perception result
At week 8, 100% of subjects agreed that skin texture felt smoother.
- Scope
- Normal-to-Dry regimen used together
- Endpoint
- consumer agreement: skin texture feels smoother
- Duration
- 8 weeks
- Source
- Validated Claim Support LLC, CS211017, n=32, consumer perception
claim 15participant-perception result
At week 8, 96.88% of subjects agreed that skin looked more luminous, radiant, or bright.
- Scope
- Normal-to-Dry regimen used together
- Endpoint
- consumer agreement: skin looks more luminous, radiant, or bright
- Duration
- 8 weeks
- Source
- Validated Claim Support LLC, CS211017, n=32, consumer perception
claim 16participant-perception result
At week 8, 96.88% of subjects said they would buy the tested product regimen.
- Scope
- Normal-to-Dry regimen used together
- Endpoint
- consumer purchase intent
- Duration
- 8 weeks
- Source
- Validated Claim Support LLC, CS211017, n=32, consumer perception
current evidence · 2 registered claims
SeneCell SenePlex+ StemCell Concentrate
claim 01measured clinical result
In an independent study, SeneCell improved measured skin hydration by up to 73.9% immediately after application.
- Scope
- SeneCell finished product
- Endpoint
- measured skin hydration
- Duration
- immediate
- Source
- Essex Testing Clinic, Panel 26025, SGF25001-01, n=31, Corneometer, p<0.001
claim 02measured clinical result
In an independent study, SeneCell improved measured skin hydration by 56.4% at 8 weeks.
- Scope
- SeneCell finished product
- Endpoint
- measured skin hydration
- Duration
- 8 weeks
- Source
- Essex Testing Clinic, Panel 26025, SGF25001-01, n=31, Corneometer, p<0.001
current evidence · 3 registered claims
G.L.P-Complex with SenePlex+ and Exosomes
claim 01measured clinical result
In an independent study, G.L.P-Complex reduced the appearance of deep wrinkles by 11.2% at 4 weeks.
- Scope
- G.L.P-Complex finished product
- Endpoint
- appearance of deep wrinkles
- Duration
- 4 weeks
- Source
- Essex Testing Clinic, Panel 26026, SGF25015-01, n=31, image analysis, p<0.001
claim 02measured clinical result
In an independent study, G.L.P-Complex reduced the appearance of deep wrinkles by 23.4% at 8 weeks.
- Scope
- G.L.P-Complex finished product
- Endpoint
- appearance of deep wrinkles
- Duration
- 8 weeks
- Source
- Essex Testing Clinic, Panel 26026, SGF25015-01, n=31, image analysis, p<0.001
claim 03measured clinical result
In an independent study, G.L.P-Complex improved the look of facial volume by 8.4% at 8 weeks.
- Scope
- G.L.P-Complex finished product
- Endpoint
- look of facial volume
- Duration
- 8 weeks
- Source
- Essex Testing Clinic, Panel 26026, SGF25015-01, n=31, image analysis, p=0.044
current evidence · 1 registered claim
NeoTight Rejuvenating Anti-Wrinkle Serum
current official product or collection · full clinical report
claim 01measured clinical result
In an independent study, Rejuvenating Anti-Wrinkle Serum improved measured net skin elasticity by 7.65% one hour after a single application.
- Scope
- Rejuvenating Anti-Wrinkle Serum finished product
- Endpoint
- measured net skin elasticity
- Duration
- baseline to 1 hour after a single application
- Source
- Validated Claim Support LLC, CS201033 / RE201033.V02, pp.5 and 21, Cutometer R5, Baseline to 1 Hour, n=32, p=0.015
current evidence · 8 registered claims
C-Bright Dark Spot Corrector
current official product or collection · full clinical report
claim 01measured clinical result
In an independent study, C-Bright improved the appearance of skin brightness by 2.3% at 4 weeks.
- Scope
- C-Bright Dark Spot Corrector finished product
- Endpoint
- image-analyzed appearance of skin brightness
- Duration
- 4 weeks
- Source
- Essex Testing Clinic, Panel 23049, ImagePro analysis, n=34, p=0.001
claim 02measured clinical result
In an independent study, C-Bright improved the appearance of skin brightness by 5.0% at 8 weeks.
- Scope
- C-Bright Dark Spot Corrector finished product
- Endpoint
- image-analyzed appearance of skin brightness
- Duration
- 8 weeks
- Source
- Essex Testing Clinic, Panel 23049, ImagePro analysis, n=34, p<0.001
claim 03measured clinical result
At 8 weeks, 88% of subjects improved on the image-analyzed skin-brightness endpoint.
- Scope
- C-Bright Dark Spot Corrector finished product
- Endpoint
- subjects improving on image-analyzed skin brightness
- Duration
- 8 weeks
- Source
- Essex Testing Clinic, Panel 23049, ImagePro analysis, n=34
claim 04measured clinical result
In an independent study, C-Bright improved the appearance of hyperpigmentation by 2.6% at 4 weeks.
- Scope
- C-Bright hyperpigmentation sub-panel
- Endpoint
- image-analyzed appearance of hyperpigmentation
- Duration
- 4 weeks
- Source
- Essex Testing Clinic, Panel 23049, ImagePro analysis, subjects 1–21, p=0.005
claim 05measured clinical result
In an independent study, C-Bright improved the appearance of hyperpigmentation by 2.5% at 8 weeks.
- Scope
- C-Bright hyperpigmentation sub-panel
- Endpoint
- image-analyzed appearance of hyperpigmentation
- Duration
- 8 weeks
- Source
- Essex Testing Clinic, Panel 23049, ImagePro analysis, subjects 1–21, p=0.021
claim 06measured clinical result
Seventy-six percent of subjects in the C-Bright hyperpigmentation sub-panel improved at the measured endpoints.
- Scope
- C-Bright hyperpigmentation sub-panel
- Endpoint
- subjects improving on image-analyzed hyperpigmentation
- Duration
- 4 and 8 weeks
- Source
- Essex Testing Clinic, Panel 23049, ImagePro analysis, subjects 1–21
claim 07measured clinical result
In an independent study, C-Bright improved the appearance of dark acne scars by 1.2% at 8 weeks.
- Scope
- C-Bright dark-acne-scar sub-panel
- Endpoint
- image-analyzed appearance of dark acne scars
- Duration
- 8 weeks
- Source
- Essex Testing Clinic, Panel 23049, ImagePro analysis, subjects 22–34, p=0.016
claim 08measured clinical result
In an independent study, C-Bright evened the appearance of skin tone by 0.3% at 8 weeks.
- Scope
- C-Bright Dark Spot Corrector finished product
- Endpoint
- image-analyzed appearance of skin-tone evenness
- Duration
- 8 weeks
- Source
- Essex Testing Clinic, Panel 23049, ImagePro analysis, n=34, p=0.041
current evidence · 9 registered claims
Current EyeCrème
claim 01clinical summary
In an eight-week independent clinical study of current EyeCrème, 87.10% of participants showed measured improvement in eye-area skin radiance and 64.52% showed a measured decrease in eye-area wrinkle appearance.
- Scope
- current EyeCrème finished product
- Endpoint
- visible eye-area radiance and wrinkle appearance
- Duration
- 8 weeks
- Source
- Current official US EyeCrème product page, verified 2026-07-10; 31-participant expert-grading and Visioscan summary
claim 02measured clinical result
After eight weeks with current EyeCrème, 87.10% of participants showed measured improvement in skin radiance in the eye area.
- Scope
- current EyeCrème finished product
- Endpoint
- participant responder rate for measured eye-area skin-radiance improvement
- Duration
- 8 weeks
- Source
- Current official US EyeCrème product page, verified 2026-07-10; independent clinical study, n=31, expert grading and Visioscan analysis compared with baseline
claim 03measured clinical result
After eight weeks with current EyeCrème, 64.52% of participants showed a measured decrease in the appearance of wrinkles in the eye area.
- Scope
- current EyeCrème finished product
- Endpoint
- participant responder rate for measured decrease in eye-area wrinkle appearance
- Duration
- 8 weeks
- Source
- Current official US EyeCrème product page, verified 2026-07-10; independent clinical study, n=31, expert grading and Visioscan analysis compared with baseline
claim 04participant-perception result
After eight weeks with current EyeCrème, 83.87% of consumer-study participants agreed that their lines and wrinkles appeared diminished.
- Scope
- current EyeCrème finished product; separate consumer-perception study
- Endpoint
- participant agreement that lines and wrinkles appeared diminished
- Duration
- 8 weeks
- Source
- Current official US EyeCrème product page, verified 2026-07-10; independent consumer study, n=31; percentage reflects participants who agreed with the statement
claim 05participant-perception result
After eight weeks with current EyeCrème, 80.65% of consumer-study participants agreed that their eye area looked more rested.
- Scope
- current EyeCrème finished product; separate consumer-perception study
- Endpoint
- participant agreement that the eye area looked more rested
- Duration
- 8 weeks
- Source
- Current official US EyeCrème product page, verified 2026-07-10; independent consumer study, n=31; percentage reflects participants who agreed with the statement
claim 06participant-perception result
After eight weeks with current EyeCrème, 77.42% of consumer-study participants agreed that their eye area looked smoother and more awake.
- Scope
- current EyeCrème finished product; separate consumer-perception study
- Endpoint
- participant agreement that the eye area looked smoother and more awake
- Duration
- 8 weeks
- Source
- Current official US EyeCrème product page, verified 2026-07-10; independent consumer study, n=31; percentage reflects participants who agreed with the statement
claim 07participant-perception result
After eight weeks with current EyeCrème, 74.19% of consumer-study participants agreed that their eye area looked more radiant.
- Scope
- current EyeCrème finished product; separate consumer-perception study
- Endpoint
- participant agreement that the eye area looked more radiant
- Duration
- 8 weeks
- Source
- Current official US EyeCrème product page, verified 2026-07-10; independent consumer study, n=31; percentage reflects participants who agreed with the statement
claim 08participant-perception result
After eight weeks with current EyeCrème, 70.97% of consumer-study participants agreed that their eye area looked refreshed and less crepey.
- Scope
- current EyeCrème finished product; separate consumer-perception study
- Endpoint
- participant agreement that the eye area looked refreshed and less crepey
- Duration
- 8 weeks
- Source
- Current official US EyeCrème product page, verified 2026-07-10; independent consumer study, n=31; percentage reflects participants who agreed with the statement
claim 09safety finding
Current EyeCrème is ophthalmologist-tested and described as safe for contact-lens wearers.
- Scope
- current EyeCrème finished product
- Endpoint
- eye-area and contact-lens-wearer suitability
- Duration
- current product safety statement
- Source
- Current official US EyeCrème product page, verified 2026-07-10